Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases

Cholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gallardo E,Jorge, Cabrera A,Elsa, Rubio L,Betzabé, González V,Carolina, Cortés A,Claudio
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2001
Materias:	Cholangiocarcinoma Cholangiography Gemcitabine
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000800010
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872001000800010
record_format	dspace
spelling	oai:scielo:S0034-988720010008000102001-10-29Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four casesGallardo E,JorgeCabrera A,ElsaRubio L,BetzabéGonzález V,CarolinaCortés A,Claudio Cholangiocarcinoma Cholangiography Gemcitabine Cholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects of chemotherapy, with a very small response. We report four patients with advanced cholangiocarcinoma, treated with gemcitabine 1000 mg/m2, weekly for 3 weeks every 28 days. There was a stabilization of tumor size and symptoms were alleviated. Toxicity was low and there was a probable prolongation of survival (Rev Méd Chile 2001; 911-6).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.8 20012001-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000800010es10.4067/S0034-98872001000800010
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Cholangiocarcinoma Cholangiography Gemcitabine
spellingShingle	Cholangiocarcinoma Cholangiography Gemcitabine Gallardo E,Jorge Cabrera A,Elsa Rubio L,Betzabé González V,Carolina Cortés A,Claudio Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases
description	Cholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects of chemotherapy, with a very small response. We report four patients with advanced cholangiocarcinoma, treated with gemcitabine 1000 mg/m2, weekly for 3 weeks every 28 days. There was a stabilization of tumor size and symptoms were alleviated. Toxicity was low and there was a probable prolongation of survival (Rev Méd Chile 2001; 911-6).
author	Gallardo E,Jorge Cabrera A,Elsa Rubio L,Betzabé González V,Carolina Cortés A,Claudio
author_facet	Gallardo E,Jorge Cabrera A,Elsa Rubio L,Betzabé González V,Carolina Cortés A,Claudio
author_sort	Gallardo E,Jorge
title	Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases
title_short	Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases
title_full	Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases
title_fullStr	Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases
title_full_unstemmed	Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases
title_sort	gemcitabina en 4 pacientes con colangiocarcinoma: report of four cases
publisher	Sociedad Médica de Santiago
publishDate	2001
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000800010
work_keys_str_mv	AT gallardoejorge gemcitabinaen4pacientesconcolangiocarcinomareportoffourcases AT cabreraaelsa gemcitabinaen4pacientesconcolangiocarcinomareportoffourcases AT rubiolbetzabe gemcitabinaen4pacientesconcolangiocarcinomareportoffourcases AT gonzalezvcarolina gemcitabinaen4pacientesconcolangiocarcinomareportoffourcases AT cortesaclaudio gemcitabinaen4pacientesconcolangiocarcinomareportoffourcases
_version_	1718435987244187648

Gemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases

Ejemplares similares